Previous Article | Next Article ![]()
Journal of Bacteriology, July 2008, p. 4818-4821, Vol. 190, No. 14
0021-9193/08/$08.00+0 doi:10.1128/JB.00255-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology, University of Washington, Seattle, Washington
Received 19 February 2008/ Accepted 7 May 2008
|
|
|---|
|
|
|---|
The deazaflavin F420 is an essential coenzyme of methanogenesis. The reduction of CO2 to methane requires reduced F420 (F420H2), since it is the sole electron donor for the step that reduces methylenetetrahydromethanopterin (methylene-H4MPT) (Mer in Fig. 1). In addition, F420H2 is the electron donor for F420H2-dependent methylenetetrahydromethanopterin dehydrogenase (Mtd), one of two enzymes that reduce methenyl-H4MPT. The other enzyme, H2-dependent methylenetetrahydromethanopterin dehydrogenase (Hmd), uses H2 directly. mRNA abundance for mtd increased markedly under hydrogen-limited growth conditions (4), suggesting that Mtd may be more important when H2 is limiting.
![]() View larger version (15K): [in a new window] |
FIG. 1. The hydrogenotrophic methanogenic pathway. See reference 3 for a full description of methanogenesis. The Hmd-Mtd cycle is boxed. Abbreviations: CoB, coenzyme B; CoM, coenzyme M; F420, coenzyme F420; Fd, ferredoxin; Frc, cysteine-containing F420-reducing hydrogenase; Fru, selenocysteine-containing F420-reducing hydrogenase; Mer, methylenetetrahydromethanopterin reductase; MFR, methanofuran.
|
Here we report on the properties of mutants of Methanococcus maripaludis that are deficient in Hmd, Mtd, or the F420-reducing hydrogenases. The results demonstrate that neither Hmd nor Mtd is essential, confirming that either enzyme is sufficient for methenyl-H4MPT reduction. The results also indicate that, in vivo, Hmd and Mtd do indeed constitute an alternate pathway for the reduction of F420 with H2, which we designate the Hmd-Mtd cycle. Furthermore, we show that during growth on formate, H2 production occurs, evidently by reversal of either the F420-reducing hydrogenase or the Hmd-Mtd cycle.
|
|
|---|
Construction of plasmids and strains.
Primers are listed in Table 1, and strains and plasmids are listed in Table 2. PCR products containing the genes hmd, mtd, frcA, and fruA and their flanking regions were generated using the primer pairs hmdcln5for and hmdcln5rev, mtdcln5for and mtdcln5rev, frcAfor2 and frcArev2, and fruAfor and fruArev, respectively. The products were cloned into pCR2.1topo to generate phmdtopo, pmtdtopo, pfrcAtopo, and pfruAtopo. An in-frame deletion of hmd was produced by PCR of phmdtopo using primers hmddel1 and hmddel2, followed by digestion with AscI and ligation to produce phmddeltopo. pmtddeltopo, pfrcAdeltopo, and pfruAdeltopol were generated in the same way using pmtdtopo and the primers mtddel1 and mtddel3, pfrcAtopo and the primers frcdel1 and frcdel2, and pfruAtopo and the primers frudel1 and frudel2, respectively. The in-frame deletion of hmd was amplified from phmddeltopo using the primers hmddelamp1 and hmddelamp3; the resulting fragment was digested with BamHI and ligated into the vector pCRprtneo to produce pCRprt
hmdneo. pCRprt
mtdneo was produced in the same way from pmtddeltopo using the primers mtddelamp1 and mtddelamp2 and digesting with BamHI. pCRprt
frcneo was produced from pfrcAdeltopo using frcdelamp5 and frcdelamp6 and digesting with XbaI, and pCRprt
fruneo was produced from pfruAdeltopo using frudelamp5 and frudelamp6 and digesting with XbaI.
|
View this table: [in a new window] |
TABLE 1. Primers
|
|
View this table: [in a new window] |
TABLE 2. Strains and plasmids
|
hmdneo, pCRprt
mtdneo, pCRprt
frcneo, and pCRprt
fruneo, respectively, to produce strains Mm1097, Mm1020, Mm1183, and Mm1145, respectively. A double mutant of frcA and fruA was constructed by the same procedure from the frcA mutant strain Mm1183 by using pCRprt
fruneo to produce Mm1184. Deletions were confirmed by Southern analysis. For experiments testing whether hmd deletion mutations could be made, pCRprt
hmdneo was transformed into recipient strains. The resultant merodiploids were streak purified, allowed to grow overnight without antibiotic selection, and plated on counterselection plates containing 8-azahypoxanthine. Colonies were analyzed by Southern blotting to distinguish strains containing deletions of the hmd gene from those containing the wild-type hmd gene. |
|
|---|
Using H2 and CO2 as growth substrates, we made the following mutants, all containing markerless in-frame deletions:
fruA,
frcA, double mutant
fruA
frcA,
mtd, and
hmd strains.
fruA
frcA,
mtd, and
hmd strains each grew normally on H2 and CO2 (Fig. 2A). Since F420H2 is essential for methanogenesis, each mutant must retain a pathway for F420 reduction using H2. Hence, the results imply that F420-reducing hydrogenase and the Mtd-Hmd cycle are each sufficient for this function.
![]() View larger version (12K): [in a new window] |
FIG. 2. Growth and H2 production by wild-type and mutant strains of M. maripaludis. (A) Growth on H2; (B) growth and H2 production on formate. For the mtd mutant on formate, data from three separate growth experiments are plotted and are represented by a single line. OD660, optical density at 660 nm.
|
hmd mutation in a
fruA
frcA background. Following our regular procedure for generation of markerless mutations (6), we introduced
hmd (containing the N- and C-terminal flanking regions of hmd) on an integrative vector to produce merodiploids of
hmd and hmd+. We made such merodiploids in the
fruA
frcA,
frcA, and fru+ frc+ backgrounds. We then selected for resolution of the merodiploids via a second recombination event and analyzed the resulting strains by Southern blotting. In principle a mixture of wild-type and deletion strains should result, depending on where the second recombination event occurs. We counted the numbers of resulting
hmd and hmd+ strains in each background. In the fru+ frc+ background six out of eight strains tested contained
hmd and the remaining two contained hmd+. In the
frcA background, which should express fru and therefore retain active F420-reducing hydrogenase, three strains contained
hmd and five contained hmd+. In contrast, in the
fruA
frcA background all 40 strains tested contained only hmd+. The results indicate that while Hmd can be eliminated in a strain with active F420-reducing hydrogenase, it is essential in a strain lacking F420-reducing hydrogenase. Therefore, no evidence could be found for the existence of a third pathway that would produce F420H2 from H2.
H2 production during growth on formate.
Growth on formate differs from growth on H2 and CO2 because F420H2 is a direct product of formate oxidation (Fig. 1). Neither the F420-reducing hydrogenase nor the Mtd-Hmd cycle should be necessary for the production of F420H2. However, the reversal of either pathway might result in H2 production. We characterized the growth of the
fruA
frcA,
mtd, and
hmd mutants on formate. The
fruA
frcA and
hmd mutants grew normally, while the
mtd mutant grew after a lag. For each strain, H2 accumulated in the headspace of the tubes as growth commenced and disappeared when growth ended (Fig. 2B). This observation suggests that H2 is produced from F420H2 and that either the F420-reducing hydrogenase or the Mtd-Hmd cycle can mediate this conversion. H2 accumulated to a substantially higher level in tubes containing cultures of the
mtd mutant than in tubes containing any of the other strains. In the
mtd strain, Hmd is the only enzyme for the reduction of methenyl-H4MPT. Therefore, H2 production, which would occur by the action of the F420-reducing hydrogenase, should be essential. Due to the relatively low affinity of Hmd for H2 (9), substantially higher H2 levels accumulate. In contrast, in the other strains Mtd is present and can use F420H2 for the reduction of methenyl-H4MPT. These results indicate that H2 production from F420H2 occurs during growth on formate and that either the F420-reducing hydrogenase or the Mtd-Hmd cycle can carry out this process.
Whether H2 is a necessary intermediate during growth on formate cannot be determined from the present data. The generation of a
fruA
frcA
hmd triple mutant, which is expected to grow in the presence of formate, could resolve this question. Growth of the mutant on formate alone without the addition or generation of H2 would indicate that H2 is not a required intermediate. A requirement for added H2 would indicate that H2 production is required during growth on formate. Efforts to construct such a mutant are under way.
Concluding remarks. The genetic approach taken here has shown that two alternative pathways, the F420-reducing hydrogenase and the Hmd-Mtd cycle, can function in vivo for the reduction of F420 with H2. Furthermore, during growth on formate the same pathways function in reverse to produce H2 from F420H2. The lack of growth differences between the wild-type and mutant strains on H2 and CO2 (Fig. 2A) suggests that neither pathway for F420 reduction was rate limiting. However, in nature the F420-reducing hydrogenase may constitute the major pathway when sufficient nickel is present, while the Hmd-Mtd cycle may be important when nickel is limiting (1, 2).
We thank William Whitman for helpful comments.
Published ahead of print on 16 May 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»